GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 633 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $11,043,000 | +204.4% | 235,000 | +176.5% | 0.02% | +214.3% |
Q3 2019 | $3,628,000 | -33.1% | 85,000 | -37.0% | 0.01% | -30.0% |
Q3 2018 | $5,423,000 | -11.7% | 135,000 | -11.4% | 0.01% | -16.7% |
Q2 2018 | $6,143,000 | +121.4% | 152,400 | +175.6% | 0.01% | 0.0% |
Q3 2013 | $2,774,000 | +0.4% | 55,297 | 0.0% | 0.01% | -14.3% |
Q2 2013 | $2,763,000 | +6.5% | 55,297 | 0.0% | 0.01% | +7.7% |
Q1 2013 | $2,594,000 | – | 55,297 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |